Gene · 27022
FOXD3: forkhead box D3
12 sourcesgene-search-2026-11-11-0.2.0
Download JSON
Cite this record
ConductScience Library. FOXD3: forkhead box D3. Genes, record 27022. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/27022
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9UJU5 | Forkhead box protein D3 | 478 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents19
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4805378 A1 | 2026-09-16 | 620 | Q9UJU5 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 46532 | Q9UJU5 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 14982 | Q9UJU5 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 14982 | Q9UJU5 | Espacenet |
| KR 1020250010750 A | 2025-01-21 | 14982 | Q9UJU5 | Espacenet |
| JP 2024109657 A | 2024-08-14 | 14821 | Q9UJU5 | Espacenet |
| US 12024722 B2 | 2024-07-02 | 32 | Q9UJU5 | Espacenet |
| JP 2023519296 A | 2023-05-10 | 55 | Q9UJU5 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 32534 | Q9UJU5 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 135505 | Q9UJU5 | Espacenet |
1 to 10 of 19
See all 19 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants983
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | FOXD3 papers | Newest fiscal year |
|---|---|---|---|
| P30CA056036 | Translational Research in Cancer | 9 | 2025 |
| R01DE017914 | Molecular Interactions during Neural Crest Formation | 8 | 2025 |
| R01DE024157 | Gene regulatory network controlling neural crest derived formation of facial cartilage | 7 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 6 | 2025 |
| P01CA163222 | Targetable epigenetic and transcriptional mechanisms in melanoma thatshape the microenvironment | 5 | 2025 |
| R01AR043369 | MITF from control of pigmentation to melanoma risk | 5 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 4 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 3 | 2025 |
| P30CA044579 | University of Virginia Cancer Center Support Grant | 3 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 3 | 2025 |
1 to 10 of 983Source NIH's project files
See all 983 nih grantsPapers1,402
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| GWAS integrating maternal and child genetics reveals novel risk-modifying loci for fetal alcohol spectrum disorders (FASD). | Res Sq | 2026 | 42818975 | PubTator, text mining | PubMed |
| FOXD3 Is Functionally Linked to NF-κB Signaling in KRAS G12C-Mutant NSCLC Cells. | Cells | 2026 | 42738858 | PubTator, text mining | PubMed |
| Partial Replacement of Fish Meal with Fish Scale Meal Enhances Body Color Brightness and Iridophore Development in Koi (Cyprinus carpio var. koi). | Animals (Basel) | 2026 | 42511112 | PubTator, text mining | PubMed |
| SIX1 branchio-oto-renal syndrome variants have different effects on embryonic craniofacial gene expression and cartilage formation. | Development | 2026 | 42290293 | PubTator, text mining | PubMed |
| BRAF inhibitor resistance in melanoma: from resistance mechanisms to therapeutic innovations. | Mol Biomed | 2026 | 41807883 | PubTator, text mining | PubMed |
| A Short Report on Melanocyte/Melanoma Culture, Senescence, and Reproducibility. | Pigment Cell Melanoma Res | 2026 | 41807282 | PubTator, text mining | PubMed |
| Ferroptosis in Parkinson's disease: a review of molecular mechanisms and emerging therapeutic strategies. | Front Neurosci | 2026 | 41799880 | PubTator, text mining | PubMed |
| Genetics of Vitiligo: A Review. | Clin Cosmet Investig Dermatol | 2026 | 41789055 | PubTator, text mining | PubMed |
| FOXC1 Regulates Cytokine Signaling, Inflammatory Pathways, and Retinoid Metabolism to Maintain Limbal Epithelial Cell Homeostasis In Vitro. | Int J Mol Sci | 2026 | 41752009 | PubTator, text mining | PubMed |
| MEP glia share molecular features with oligodendrocytes while maintaining a distinct hybrid signature. | MicroPubl Biol | 2026 | 41660199 | PubTator, text mining | PubMed |
1 to 10 of 1,402
See all 1,402 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/27022
GET https://conductscience.org/api/genes/v1/27022/patents